Ketohexokinase inhibitor 1

Ketohexokinase inhibitor 1 구조식 이미지
카스 번호:
2102501-84-6
상품명:
Ketohexokinase inhibitor 1
동의어(영문):
MDK1846;PF-06835919;Ketohexokinase-In-1;KETOHEXOKINASE INHIBITO;Ketohexokise inhibitor 1;Ketohexokinase inhibitor 1;3-Azabicyclo[3.1.0]hexane-6-aceticacid,3-[2-[(2S)-2-methyl-1-azetidinyl]-6-(trifluoromethyl)-4-pyrimidinyl]-,(1R,5S)-;2-[(1S,5R)-3-[2-[(2S)-2-methylazetidin-1-yl]-6-(trifluoromethyl)pyrimidin-4-yl]-3-azabicyclo[3.1.0]hexan-6-yl]acetic acid;2-((1R,5S,6R)-3-(2-((S)-2-methylazetidin-1-yl)-6-(trifluoromethyl)pyrimidin-4-yl)-3-azabicyclo[3.1.0]hexan-6-yl)acetic acid
CBNumber:
CB14674080
분자식:
C16H19F3N4O2
포뮬러 무게:
356.35
MOL 파일:
2102501-84-6.mol

Ketohexokinase inhibitor 1 속성

끓는 점
541.2±60.0 °C(Predicted)
밀도
1.415±0.06 g/cm3(Predicted)
저장 조건
Store at -20°C
용해도
DMSO:100.0(Max Conc. mg/mL);280.62(Max Conc. mM)
산도 계수 (pKa)
4.66±0.10(Predicted)

안전

Ketohexokinase inhibitor 1 C화학적 특성, 용도, 생산

Ketohexokinase inhibitor 1 준비 용품 및 원자재

원자재

준비 용품


Ketohexokinase inhibitor 1 공급 업체

글로벌( 44)공급 업체
공급자 전화 이메일 국가 제품 수 이점
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795
ivan@atkchemical.com China 32760 60
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000
marketing@targetmol.com United States 19892 58
Career Henan Chemica Co
+86-0371-86658258 +8613203830695
laboratory@coreychem.com China 30253 58
NINGBOBENKANGJS PHARMTECHCO., LTD
+8615990591583 15990591583
CHINA 2029 58
Zhejiang J&C Biological Technology Co.,Limited
+1-2135480471 +1-2135480471
sales@sarms4muscle.com China 10522 58
InvivoChem
+1-708-310-1919 +1-13798911105
sales@invivochem.cn United States 6393 58
Zibo Hangyu Biotechnology Development Co., Ltd
+86-0533-2185556 +8617865335152
Mandy@hangyubiotech.com China 10978 58
Suzhou ARTK Medchem Co., Ltd.
+8618168183658
sales1@artkmedchem.com China 39009 58
Wuhan Jingkang en Biomedical Technology Co., Ltd
+8613720134139
orders@jknbiochem.com China 4692 58
Shanghai Lollane Biological Technology Co.,Ltd. 021-52996696,15000506266 15000506266
China 4217 55

Copyright 2019 © ChemicalBook. All rights reserved